Leslie LA, Gangan N, Tan H, Huang Q, Yan J. Clinico-economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemia. J Current Med Res Opinion [Internet]. 2022 May 30 [cited 2026 Aug. 21];5(05). Available from: https://cmro.in/index.php/jcmro/article/view/520